Literature DB >> 15733845

Ser475, Glu272, Asp276, Asp327, and Asp360 are involved in catalytic activity of human tripeptidyl-peptidase I.

Mariusz Walus1, Elizabeth Kida, Krystyna E Wisniewski, Adam A Golabek.   

Abstract

Tripeptidyl-peptidase I (TPP I) is a lysosomal aminopeptidase that sequentially removes tripeptides from small polypeptides and also shows a minor endoprotease activity. Mutations in TPP I are associated with a fatal lysosomal storage disorder--the classic late-infantile form of neuronal ceroid lipofuscinoses. In the present study, we analyzed the catalytic mechanism of the human enzyme by using a site-directed mutagenesis. We demonstrate that apart from previously identified Ser475 and Asp360, also Glu272, Asp276, and Asp327 are important for catalytic activity of the enzyme. Involvement of serine, glutamic acid, and aspartic acid in the catalytic reaction validates the idea, formulated on the basis of significant amino acid sequence homology and inhibition studies, that TPP I is the first mammalian representative of a growing family of serine-carboxyl peptidases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733845     DOI: 10.1016/j.febslet.2005.01.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  The QM/MM molecular dynamics and free energy simulations of the acylation reaction catalyzed by the serine-carboxyl peptidase kumamolisin-As.

Authors:  Qin Xu; Hao-Bo Guo; Alexander Wlodawer; Toru Nakayama; Hong Guo
Journal:  Biochemistry       Date:  2007-02-28       Impact factor: 3.162

2.  A critical tryptophan and Ca2+ in activation and catalysis of TPPI, the enzyme deficient in classic late-infantile neuronal ceroid lipofuscinosis.

Authors:  Salomon Kuizon; Kathleen DiMaiuta; Marius Walus; Edmund C Jenkins; Marisol Kuizon; Elizabeth Kida; Adam A Golabek; Daniel O Espinoza; Raju K Pullarkat; Mohammed A Junaid
Journal:  PLoS One       Date:  2010-08-03       Impact factor: 3.752

3.  Prosegment of tripeptidyl peptidase I is a potent, slow-binding inhibitor of its cognate enzyme.

Authors:  Adam A Golabek; Natalia Dolzhanskaya; Marius Walus; Krystyna E Wisniewski; Elizabeth Kida
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

4.  Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis.

Authors:  Jayita Guhaniyogi; Istvan Sohar; Kalyan Das; Ann M Stock; Peter Lobel
Journal:  J Biol Chem       Date:  2008-11-26       Impact factor: 5.157

5.  Neuronal ceroid lipofuscinosis type CLN2: a new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America.

Authors:  Romina Kohan; María Noelia Carabelos; Winnie Xin; Katherine Sims; Norberto Guelbert; Inés Adriana Cismondi; Patricia Pons; Graciela Irene Alonso; Mónica Troncoso; Scarlet Witting; David A Pearce; Raquel Dodelson de Kremer; Ana María Oller-Ramírez; Inés Noher de Halac
Journal:  Gene       Date:  2012-12-22       Impact factor: 3.688

6.  Lysosomal serine protease CLN2 regulates tumor necrosis factor-alpha-mediated apoptosis in a Bid-dependent manner.

Authors:  Hélène Autefage; Virginie Albinet; Virginie Garcia; Hortense Berges; Marie-Laure Nicolau; Nicole Therville; Marie-Françoise Altié; Catherine Caillaud; Thierry Levade; Nathalie Andrieu-Abadie
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

7.  Structure-function analysis of Sedolisins: evolution of tripeptidyl peptidase and endopeptidase subfamilies in fungi.

Authors:  Facundo Orts; Arjen Ten Have
Journal:  BMC Bioinformatics       Date:  2018-12-04       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.